149 results on '"Weinhäuser, Isabel"'
Search Results
2. Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained setting
3. Dietary methionine starvation impairs acute myeloid leukemia progression
4. Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
5. The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia
6. Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability
7. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
8. A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction
9. Acute promyelocytic leukaemia in low-income and middle-income countries: a Brazilian experience
10. Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia
11. Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia
12. Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort
13. Thiostrepton induces cell death of acute myeloid leukemia blasts and the associated macrophage population
14. PB1772: HIGH SLIT2 LEVELS ARE ASSOCIATED WITH GMP LIKE AML AND TREATMENT WITH RECOMBINANT SLIT2 INHIBITS LEUKEMOGENESIS
15. P1345: EFFECT OF DECITABINE ON MACROPHAGE PHENOTYPE AND FUNCTION IN VITRO IN THE CONTEXT OF AML
16. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
17. Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained setting
18. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
19. Intrinsic and extrinsic factors driving leukaemogenesis
20. High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia
21. Targeting PIP4K2 Lipid Kinases through Thz-P1-2 Reveals Vulnerabilities Related to Mitochondrial Homeostasis and Autophagy in Acute Leukemia
22. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia
23. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
24. M2-polarized macrophages control LSC fate by enhancing stemness, homing, immune evasion and metabolic reprogramming
25. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
26. Tumor Associated Macrophages Promoted Fatal Patient Derived Acute Promyelocytic Leukemia In Vivo
27. Clinical Significance of Mitochondrial DNA Content in Acute Promyelocytic Leukemia
28. Treatment with the Recombinant SLIT2 Protein Delays AML Leukemogenesis In Vivo
29. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.
30. High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia.
31. The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia
32. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
33. The Expression of NTAL and Its Protein Interactors Is Associated With Clinical Outcomes in Acute Myeloid Leukemia
34. Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia
35. Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis
36. MN1 Expression Is an Indepedent Prognostic Marker in FLT3-Mutated Acute Myeloid Leukemia and Is Involved in the Resistance to FLT3 Inhibitors
37. Metformin Suppress Cellular and Molecular Processes Related to Maintenance and Proliferation of Myeloproliferative Neoplasm Stem Cell
38. Arsenic Trioxide Abrogate MN1 Mediated RA-Resistance in Acute Promyelocytic Leukemia
39. Reduced SLIT2 Are Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in APL Cells
40. Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia
41. Efficacy of the Pan-Bcl-2 Inhibitor (Obatoclax) As a Single Agent to Treat Myeloproliferative Neoplasm in JAK2V617F Murine Transplantation Model
42. Association betweenANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS‐genotyped patients
43. High MN1 Expression Is Associated with an Lspc-Enriched Phenotype and Glycolysis Representing a New Vulnerability in Acute Myeloid Leukemia
44. Impaired Metabolic Plasticity Under Stress Constitutes a Therapeutic Vulnerability in IDH1/2-Mutant Acute Myeloid Leukemia
45. Functional Drug Screen Identifies Thiostrepton, NAMPT Inhibitors and Metformin As Potential Candidates to Target the Macrophage Tumor Microenvironment in Acute Myeloid Leukemia
46. M2 Macrophages Drive Resistance to Phagocytosis and Improve Mitochondrial Metabolism in Acute Myeloid Leukemia Facilitating Leukemic Transformation and In Vivo Engraftment
47. Slit-Robo Pathway Is Clinically Relevant and May Represent a Potential Target in Acute Promyelocytic Leukemia
48. Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression
49. KMT2E-Mediated Epigenetic Reprogramming Promotes the Sensitivity to All-Trans Retinoic Acid and Increases the Granulocytic Differentiation in AML Cells
50. Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS‐genotyped patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.